Aucta is a global brand that creates better products from proven molecules.
Reset all filters
01 1Aucta Pharmaceuticals
02 2Towa Pharmaceutical
03 1Acme Lifetech
04 1Aeron Remedies
05 2Alter Laboratories Sa
06 4Aurobindo Pharma Limited
07 2Caristar Laboratories
08 2Cinfa
09 2Delius Pharmaceuticals
10 2Dycine Pharma
11 2Efarmes Sau
12 5Faes Farma
13 1Halewood Laboratories Pvt. Ltd
14 1Hanlim Pharmaceuticals Inc
15 2Kern Pharma S.L.
16 3LAB.GUIDOTTI SpA
17 2LABORATORIOS NORMON SA
18 3Menarini
19 1Myungmoon Pharm. Co., LTD.
20 5PTC Therapeutics
21 2STADA Arzneimittel
22 2Sandoz B2B
23 6Sun Pharmaceutical Industries Limited
24 2Swasthya Healthcare
25 3TEOFARMA Srl
26 1Tarbis Farma Sl
27 1Themis Medicare
28 1Tris Pharma Inc
29 1Unicor Pharmatech
30 5Upsher-Smith Laboratories
31 1Vaishali Pharma Ltd
32 1Vega Biotech Pvt. Ltd.
33 2Vir Sa Chemical And Pharmaceutical Industry
34 2Xgx Pharma Aps
35 5ZRS LABS
36 1Zota Healthcare Ltd
37 4Zydus Lifesciences
Reset all filters
01 2Oral Drop In Suspension
02 4SUSPENSION;ORAL
03 1Syrup
04 5TABLET
05 20TABLET;ORAL
06 46Tablet
07 6Blank
Reset all filters
01 2Approved
02 21Authorized
03 6Cancelled
04 4Generic
05 1Generic B.E study
06 24RX
07 2Suspensed
08 24Blank
Reset all filters
01 1CORTOSEPT-30
02 1CORTOSEPT-6
03 1Cerdef
04 1DEFLA
05 14DEFLAZACORT
06 2Defal
07 3Deflan
08 2Deflazacort Alter
09 2Deflazacort Cinfa
10 1Deflazacort Consumption
11 2Deflazacort Efarmes
12 2Deflazacort Kern Pharma
13 2Deflazacort Normon
14 2Deflazacort Pensa
15 2Deflazacort Sandoz
16 2Deflazacort Stada
17 2Deflazacort Sun
18 2Deflazacort Vir
19 2Deflazacort Xgx Pharma
20 2Delflaz 6
21 3Dezacor
22 5EMFLAZA
23 1FLAZARON 6
24 3Flantadin
25 1Inflacort
26 4JAYTHARI
27 1PYQUVI
28 1Telacort
29 3Zamene
30 14Blank
Reset all filters
01 21India
02 6Italy
03 2South Korea
04 29Spain
05 2Sweden
06 24USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PYQUVI
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 22.75MG/ML
Packaging :
Approval Date : 2025-06-30
Application Number : 219417
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Deflazacort Pensa
Dosage Form : Tablet
Dosage Strength : 30MG
Packaging :
Approval Date : 2011-04-13
Application Number : 73882
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Suspensed
Registration Country : Spain
Brand Name : Deflazacort Pensa
Dosage Form : Tablet
Dosage Strength : 6MG
Packaging :
Approval Date : 2011-04-13
Application Number : 73883
Regulatory Info : Suspensed
Registration Country : Spain
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 6MG
Packaging :
Approval Date : 2024-02-09
Application Number : 217123
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 18MG
Packaging :
Approval Date : 2024-02-09
Application Number : 217123
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2024-02-09
Application Number : 217123
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 36MG
Packaging :
Approval Date : 2024-02-09
Application Number : 217123
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : EMFLAZA
Dosage Form : TABLET;ORAL
Dosage Strength : 6MG
Packaging :
Approval Date : 2017-02-09
Application Number : 208684
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : EMFLAZA
Dosage Form : TABLET;ORAL
Dosage Strength : 18MG
Packaging :
Approval Date : 2017-02-09
Application Number : 208684
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : EMFLAZA
Dosage Form : TABLET;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2017-02-09
Application Number : 208684
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : EMFLAZA
Dosage Form : TABLET;ORAL
Dosage Strength : 36MG
Packaging :
Approval Date : 2017-02-09
Application Number : 208684
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : EMFLAZA
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 22.75MG/ML
Packaging :
Approval Date : 2017-02-09
Application Number : 208685
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 6MG
Packaging :
Approval Date : 2025-03-18
Application Number : 217741
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 18MG
Packaging :
Approval Date : 2025-03-18
Application Number : 217741
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2025-03-18
Application Number : 217741
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 6MG
Packaging :
Approval Date : 2024-11-05
Application Number : 216720
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 18MG
Packaging :
Approval Date : 2024-11-05
Application Number : 216720
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2024-11-05
Application Number : 216720
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : TABLET;ORAL
Dosage Strength : 36MG
Packaging :
Approval Date : 2024-11-05
Application Number : 216720
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DEFLAZACORT
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 22.75MG/ML
Packaging :
Approval Date : 2025-08-11
Application Number : 216992
Regulatory Info : RX
Registration Country : USA